278 related articles for article (PubMed ID: 12597338)
1. The influence of BMOV [bis(maltolato)oxovanadium(IV)] on biochemical and morphological alterations characteristic for streptozotocin-diabetic rat liver Golgi complexes.
Dabroś W; Dziga D; Kordowiak AM
Pol J Pathol; 2002; 53(4):205-13. PubMed ID: 12597338
[TBL] [Abstract][Full Text] [Related]
2. Influence of bis(maltolato)oxovanadium(IV) on activity of galactosyltransferase (GalT) and morphology of rat liver Golgi apparatus in control and streptozotocin diabetes.
Dabroś W; Kordowiak AM; Dziga D; Gryboś R
Pol J Pathol; 1998; 49(2):67-76. PubMed ID: 9798409
[TBL] [Abstract][Full Text] [Related]
3. Sodium metavanadate affected control and streptozotocin-diabetic rat liver golgi complexes.
Dabroś W; Goc A; Turyna B; Kordowiak AM
Pol J Pathol; 2006; 57(2):91-7. PubMed ID: 17019971
[TBL] [Abstract][Full Text] [Related]
4. Streptozotocin-induced alterations in rat liver Golgi complexes are ameliorated by BMOV [Bis(maltolato)oxovanadium(IV)] activity.
Kordowiak AM; Dziga D; Dabroś W
Horm Metab Res; 2004 Mar; 36(3):148-54. PubMed ID: 15057667
[TBL] [Abstract][Full Text] [Related]
5. The influence of a new vanadium compound, bis(2,2'-bipyridine)oxovanadium(IV) sulphate on liver golgi complexes from control and streptozotocin-diabetic rats.
Kordowiak AM; Dabroś W; Kajda B
Horm Metab Res; 2002 Oct; 34(10):556-60. PubMed ID: 12439783
[TBL] [Abstract][Full Text] [Related]
6. Biochemical and morphological alterations in rat liver Golgi complexes after treatment with bis(maltolato)oxovanadium(IV) [BMOV] or maltol alone.
Dabroś W; Dziga D; Gryboś R; Kordowiak AM
Pathol Res Pract; 2000; 196(8):561-8. PubMed ID: 10982019
[TBL] [Abstract][Full Text] [Related]
7. Biochemical and morphological study on liver Golgi complex in streptozotocin-diabetic and control rats treated with bis(kojato)oxovanadium(IV) [VO(ka)2]x2H2O. Part II. Prolonged treatmentwith vanadium compound.
Dabroś W; Gryboś R; Miarka A; Kordowiak AM
Pol J Pathol; 2000; 51(1):17-24. PubMed ID: 10833899
[TBL] [Abstract][Full Text] [Related]
8. Biochemical and morphological study on liver Golgi complex in streptozotocin-diabetic and control rats treated with bis(kojato)oxovanadium(IV) [VO(ka)2]x2H2O. Part I. One week treatment with vanadium compound.
Kordowiak AM; Nikiforuk A; Dabroś W
Pol J Pathol; 2000; 51(1):9-16. PubMed ID: 10833898
[TBL] [Abstract][Full Text] [Related]
9. Control and STZ-diabetic rat liver Golgi complexes under the influence of bis(2,2'-bipyridine)oxovanadium(IV) sulphate. The morphological investigation.
Dabroś W; Kajda B; Kordowiak AM
Pol J Pathol; 2002; 53(3):123-8. PubMed ID: 12476613
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like effects on liver Golgi membrane preparations of bis(oxalato)oxovanadate(IV) complex ion, a new vanadate compound.
Kordowiak AM; Trzos R; Grybos R
Horm Metab Res; 1997 Mar; 29(3):101-5. PubMed ID: 9137978
[TBL] [Abstract][Full Text] [Related]
11. Sodium orthovanadate exerts influence on liver Golgi complexes from control and streptozotocin-diabetic rats.
Kordowiak AM; Goc A; Drozdowska E; Turyna B; Dabros W
J Inorg Biochem; 2005 May; 99(5):1083-9. PubMed ID: 15833331
[TBL] [Abstract][Full Text] [Related]
12. Morphology and biochemical activity of rat liver golgi complexes after pretreatment with bis(kojato)oxovanadium(IV) or kojic acid alone.
Dabroś W; Nikiforuk A; Kordowiak AM
Pol J Pathol; 2004; 55(3):15-21. PubMed ID: 15619976
[TBL] [Abstract][Full Text] [Related]
13. Influence of LEPK on biochemical activity and morphology in situ of liver Golgi apparatus from control and streptozotocin-diabetic rats.
Kordowiak AM; Polański M; Dabroś W
Pol J Pathol; 1997; 48(2):87-93. PubMed ID: 9278104
[TBL] [Abstract][Full Text] [Related]
14. Influence of vanadyl sulphate [VOSO4] on biochemical activity and morphology of control and streptozotocin-diabetic rat liver Golgi complexes.
Dabroś W; Goc A; Turyna B; Kordowiak AM
Pol J Pathol; 2004; 55(1):25-32. PubMed ID: 15195703
[TBL] [Abstract][Full Text] [Related]
15. Effect of chronic treatment with Bis(maltolato)oxovanadium (IV) in rat model of non-insulin-dependent-diabetes.
Shinde UA; Mehta AA; Goyal RK
Indian J Exp Biol; 2001 Sep; 39(9):864-70. PubMed ID: 11831366
[TBL] [Abstract][Full Text] [Related]
16. Effect of bis(maltolato)oxovanadium (IV) (BMOV) on selenium nutritional status in diabetic streptozotocin rats.
Sanchez-Gonzalez C; Bermudez-Peña C; Guerrero-Romero F; Trenzado CE; Montes-Bayon M; Sanz-Medel A; Llopis J
Br J Nutr; 2012 Sep; 108(5):893-9. PubMed ID: 22085676
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms by which bis(maltolato)oxovanadium(IV) normalizes phosphoenolpyruvate carboxykinase and glucose-6-phosphatase expression in streptozotocin-diabetic rats in vivo.
Marzban L; Rahimian R; Brownsey RW; McNeill JH
Endocrinology; 2002 Dec; 143(12):4636-45. PubMed ID: 12446591
[TBL] [Abstract][Full Text] [Related]
18. The activity of Golgi-membrane galactosyltransferase in the liver of streptozotocin-diabetic rats.
Sarnecka-Keller M; Kordowiak A
Acta Biochim Pol; 1977; 24(3):179-85. PubMed ID: 145156
[TBL] [Abstract][Full Text] [Related]
19. Comparison of bipyridyl, maltol and kojic acid action as organic vanadium ligands on activity of galactosyltransferase (EC 2.4.1.38), some physiological parameters and ultrastructure of Golgi complexes in rat hepatocytes.
Dabros W; Kordowiak A
Folia Histochem Cytobiol; 2007; 45(3):239-44. PubMed ID: 17951174
[TBL] [Abstract][Full Text] [Related]
20. Comparison of rat plasma glycoprotein composition with biochemical activity and morphology of liver Golgi apparatus in streptozotocin diabetes treated with insulin.
Kordowiak A; Turyna B; Kaczmarski F; Sarnecka-Keller M
Folia Histochem Cytochem (Krakow); 1981; 19(4):181-8. PubMed ID: 6460671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
